Synthesis and secretion of apoE in thioglycolate-elicited mouse peritoneal macrophages: effect of cholesterol efflux.
ApoE synthesis and secretion, as a function of cellular cholesterol content and cholesterol efflux, was studied in thioglycolate-elicited mouse peritoneal macrophages. As expected, loading elicited macrophages with cholesterol induced a 5-fold increase in apoE secretion and a 2.5-fold increase in cellular apoE content over a 5-h period. Treatment of cholesterol-loaded cells with HDL3 further increased apoE secretion 1.7-fold and decreased cellular cholesterol by 20%. Treatment of cholesterol-loaded cells with HDL3 and SAH 58.035 (an ACAT inhibitor) increased apoE secretion 2.4-fold and decreased cellular cholesterol content by 35%. Treatment of the cells with the ACAT inhibitor alone suppressed apoE secretion by 40% but did not change cellular cholesterol content. Northern blot analysis of RNA indicated that cholesterol loading increased apoE mRNA 2-fold. ApoE mRNA levels were not further affected by treatment with HDL3 and/or the ACAT inhibitor. Cholesterol-loaded cells, in the absence of HDL3, secreted apoE into the media in two fractions as determined by column chromatography: a large molecular weight complex, (larger than HDL), and an essentially lipid-free protein. In the presence of HDL3, the cells secreted apoE in three fractions: a large molecular weight complex, an essentially lipid-free protein, and over 50% of apoE associated with HDL. In the process, HDL3 became larger and eluted in a position identical to that of HDL2. A small amount of HDL3-derived material was also transformed to an LDL-size particle. Incubation of HDL3 in the absence of cholesterol-loaded cells did not produce these changes. It is concluded that cholesterol-loading increases apoE mRNA content and apoE synthesis.(ABSTRACT TRUNCATED AT 250 WORDS)
Dory
L
L
Department of Pharmacology, College of Medicine, University of Tennessee, Memphis 38163.
D000577:Amides / Q000378:metabolism; D000818:Animals; D001057:Apolipoproteins E / Q000096:biosynthesis* / Q000378:metabolism; D015152:Blotting, Northern; D002784:Cholesterol / Q000378:metabolism*; D002850:Chromatography, Gel; D004591:Electrophoresis, Polyacrylamide Gel; D008075:Lipoproteins, HDL / Q000494:pharmacology; D053440:Lipoproteins, HDL3; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism*; D051379:Mice; D017646:Organosilicon Compounds; D010529:Peritoneal Cavity; D012313:RNA / Q000032:analysis; D002785:Sterol O-Acyltransferase / Q000032:analysis; D013864:Thioglycolates / Q000494:pharmacology*; D013997:Time Factors
D000577:Amides; D001057:Apolipoproteins E; D008075:Lipoproteins, HDL; D053440:Lipoproteins, HDL3; D017646:Organosilicon Compounds; D013864:Thioglycolates; D012313:RNA; C040256:SAN 58035; D002784:Cholesterol; D002785:Sterol O-Acyltransferase